(a)
Shipping non-creditable hazardous waste pharmaceuticals or evaluated hazardous waste pharmaceuticals. A
healthcare facility must ship non-creditable
hazardous waste pharmaceuticals and a
reverse distributor must ship evaluated
hazardous waste pharmaceuticals off-
site to a designated
facility (such as a permitted or interim status treatment, storage, or disposal
facility) in compliance with:
(1) The following pre-transport requirements, before transporting or offering for transport off-
site:
(i)
Packaging. Package the
waste in accordance with the applicable
Department of
Transportation regulations on hazardous materials under 49 CFR parts 173, 178, and 180.
(ii)
Labeling. Label each
package in accordance with the applicable
Department of
Transportation regulations on hazardous materials under 49 CFR part 172 subpart E.
(iii)
Marking.
(A) Mark each
package of
hazardous waste pharmaceuticals in accordance with the applicable
Department of Transportation (
DOT) regulations on hazardous materials under 49 CFR part
172 subpart D;
(B) Mark each container of 119 gallons or less used in such transportation with the following words and information in accordance with the requirements of 49 CFR
172.304:
HAZARDOUS WASTE-Federal Law Prohibits Improper Disposal. If found, contact the nearest police or public safety authority or the U.S. Environmental Protection Agency.
Healthcare Facility's or Reverse distributor's Name and Address Healthcare Facility's or Reverse distributor's EPA Identification Number Manifest Tracking Number
(C) Lab packs that will be incinerated in compliance with § 268.42(c) of these regulations are not required to be marked with EPA Hazardous Waste Number(s) (i.e., hazardous waste codes), except D004, D005, D006, D007, D008, D010, and D011, where applicable. A nationally recognized electronic system, such as bar coding or radio frequency identification tag, may be used to identify the applicable EPA Hazardous Waste Number(s) (i.e., hazardous waste codes).
(iv)
Placarding. Placard or offer the initial transporter the appropriate placards according to
Department of Transportation regulations for hazardous materials under 49 CFR part
172 subpart F.
(2) The manifest requirements of Part 262 Subpart B, except that:
(i) A healthcare facility shipping non-creditable hazardous waste pharmaceuticals is not required to list all applicable EPA hazardous waste numbers (i.e., hazardous waste codes) in Item 13 of EPA Form 8700-22.
(ii) A healthcare facility shipping non-creditable hazardous waste pharmaceuticals must write the word "PHARMS" in Item 13 of EPA Form 8700-22.
(b)
Exporting non-creditable hazardous waste pharmaceuticals or evaluated hazardous waste pharmaceuticals. A
healthcare facility or
reverse distributor that exports non-creditable
hazardous waste pharmaceuticals or evaluated
hazardous waste pharmaceuticals is subject to 40 CFR part
262 subpart H.
(c)
Importing non-creditable hazardous waste pharmaceuticals or evaluated hazardous waste pharmaceuticals. Any
person that imports non-creditable
hazardous waste pharmaceuticals or evaluated
hazardous waste pharmaceuticals is subject to 40 CFR part
262 subpart H. A
healthcare facility or
reverse distributor may not accept imported non-creditable
hazardous waste pharmaceuticals or evaluated
hazardous waste pharmaceuticals unless they have a
permit or interim status that allows them to accept
hazardous waste from off
site.
Notes
6 CCR 1007-3-267.508
37 CR 24, December 25, 2014, effective 3/2/2015
38 CR 11, June 10, 2015, effective 6/30/2015
39 CR 05, March 10, 2016, effective 3/30/2016
39 CR 11, June 10, 2016, effective 6/30/2016
40 CR 06, March 25, 2017, effective 4/14/2017
40 CR 11, June 10, 2017, effective 6/30/2017
40 CR 21, November 10, 2017, effective 11/30/2017
41 CR 06, March 25, 2018, effective 4/14/2018
41 CR 11, June 10, 2018, effective 6/30/2018
41 CR 24, December 25, 2018, effective 1/14/2019
42 CR 06, March 25, 2019, effective 4/14/2019
42 CR 06, March 25, 2019, effective 5/30/2019
42 CR 11, June 10, 2019, effective 6/30/2019
43 CR 12, June 25, 2020, effective 7/15/2020
44 CR 06, March 25, 2021, effective 4/14/2021
44 CR 11, June 10, 2021, effective 6/30/2021
44 CR 24, December 25, 2021, effective 1/14/2022
45 CR 11, June 10, 2022, effective 6/30/2022
45 CR 17, September 10, 2022, effective 9/10/2022
45 CR 17, September 10, 2022, effective 9/30/2022
45 CR 23, December 10, 2022, effective 1/30/2023
47 CR 18, September 25, 2024, effective 10/15/2024